Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

National Competition for Investigator Program

Howard Hughes Medical Institute

Overview

We believe that the most transformative breakthroughs come when talented scientists are given the freedom to pursue bold ideas.

That’s why we take a “people, not projects” approach, providing generous and flexible support to talented scientists so they can go where their science leads.

We employ more than 260 Investigators, located at approximately 60 US research institutions, who are widely known for pushing the boundaries of basic and biomedical research.

In addition to conducting original research, HHMI Investigators also:

Direct a research team and create a lab environment suited to tackling fundamental research questions
Commit to mentoring and training the next generation of scientists
Join an active community of HHMI scientists spanning career stages
Teach and play leadership roles at their host institutions

HHMI Investigators do research that radically changes our understanding of how biology works, from molecular, biochemical and cellular processes to genetics, development and disease mechanisms, in a wide range of organisms. These fundamental discoveries have been broadly recognized by the scientific community, including Nobel Prizes to more than 30 current or former Investigators.

Specialties

Eligibility Requirements

In general, to be eligible for the Investigator program, applicants must:

Have a PhD and/or MD
Plan to dedicate at least 75% of their time to research at an eligible US institution
Hold a position that represents substantial commitment by their institution, such as a tenure-track faculty position
Have a track record of peer-reviewed funding
Meet the required length of post-training, professional experience prior to applying

Investigator competitions are open to researchers in basic and biomedical sciences, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology.

To determine your eligibility to apply to the 2024 HHMI Investigator competition, log in to HHMI’s Application and Review Channel (ARC), or register if you are a first time user. Note, to register, you must have an ORCID identifier (ORCID iD). Once logged in, you will submit information relevant to HHMI’s eligibility requirements and acknowledge conditions required for appointment as an HHMI Investigator. You will immediately find out if you are eligible to apply. The full application will open in December 2022.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: Howard Hughes Medical Institute

Sponsor Type:

Address: Howard Hughes Medical Institute; 4000 Jones Bridge Road; Chevy Chase; MD 20815-6789; United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity